---
figid: PMC4761092__BPH-173-856-g010
figlink: /pmc/articles/PMC4761092/figure/bph13394-fig-0010/
number: F10
caption: Scheme of the role of (+)‐naltrexone and (+)‐naloxone in TLR4 signalling.
  TLR4 signals via two main pathways involving the adaptor proteins, MyD88 or TRIF.
  MyD88‐dependent signalling induces activation of the transcription factors NF‐κB
  and AP‐1. TRIF‐dependent signalling causes the activation of NF‐κB and IRF3. NF‐κB
  and AP‐1 activation results in the induction of pro‐inflammatory cytokines. IRF3
  activation induces type I IFN production. IFN‐β activates the type I IFN receptor
  and its corresponding JAK‐STAT pathway in an autocrine and paracrine fashion, leading
  to the production of inducible NOS. It should be pointed out that these TLR4 signalling
  pathways have been well characterized (Takeuchi and Akira, 2010). (+)‐Naltrexone
  and (+)‐naloxone bind to the MD2 and biasedly inhibit the TLR4‐TRIF‐IRF3 signalling
  pathway (thin line). The unaffected signalling pathway is represented by a thick
  line.
pmcid: PMC4761092
papertitle: Pharmacological characterization of the opioid inactive isomers (+)‐naltrexone
  and (+)‐naloxone as antagonists of toll‐like receptor 4.
reftext: X Wang, et al. Br J Pharmacol. 2016 Mar;173(5):856-869.
pmc_ranked_result_index: '14826'
pathway_score: 0.956482
filename: BPH-173-856-g010.jpg
figtitle: Scheme of the role of (+)‐naltrexone and (+)‐naloxone in TLR4 signalling
year: '2016'
organisms:
- Homo sapiens
ndex: edad4f9b-deb0-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4761092__BPH-173-856-g010.html
  '@type': Dataset
  description: Scheme of the role of (+)‐naltrexone and (+)‐naloxone in TLR4 signalling.
    TLR4 signals via two main pathways involving the adaptor proteins, MyD88 or TRIF.
    MyD88‐dependent signalling induces activation of the transcription factors NF‐κB
    and AP‐1. TRIF‐dependent signalling causes the activation of NF‐κB and IRF3. NF‐κB
    and AP‐1 activation results in the induction of pro‐inflammatory cytokines. IRF3
    activation induces type I IFN production. IFN‐β activates the type I IFN receptor
    and its corresponding JAK‐STAT pathway in an autocrine and paracrine fashion,
    leading to the production of inducible NOS. It should be pointed out that these
    TLR4 signalling pathways have been well characterized (Takeuchi and Akira, 2010).
    (+)‐Naltrexone and (+)‐naloxone bind to the MD2 and biasedly inhibit the TLR4‐TRIF‐IRF3
    signalling pathway (thin line). The unaffected signalling pathway is represented
    by a thick line.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - FOSL1
  - JUND
  - IFNB1
  - NFKB1
  - MAPK10
  - JUNB
  - MAPK9
  - MAPK12
  - MYD88
  - MAPK13
  - IL16
  - TNF
  - FOSL2
  - JUN
  - MAPK8
  - STAT1
  - IRF3
  - STAT2
  - STAT3
  - MAPK11
  - TLR4
  - FOS
  - STAT5B
  - STAT6
  - JAK2
  - FOSB
  - STAT5A
  - JAK1
  - MAPK3
  - STAT4
  - MAPK1
  - TYK2
  - MAPK14
  - JAK3
  - (+)-Naloxone
  - (+)-Naltrexone
genes:
- word: AP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOSL1
  entrez: '8061'
- word: AP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: JUND
  entrez: '3727'
- word: IFN-B
  symbol: IFNB
  source: bioentities_symbol
  hgnc_symbol: IFNB1
  entrez: '3456'
- word: NF-KB
  symbol: NF-kappaB
  source: hgnc_alias_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: AP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: JUNB
  entrez: '3726'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: MYD88
  symbol: MYD88
  source: hgnc_symbol
  hgnc_symbol: MYD88
  entrez: '4615'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: IL-16
  symbol: IL-16
  source: hgnc_alias_symbol
  hgnc_symbol: IL16
  entrez: '3603'
- word: TNF-a
  symbol: TNF-alpha
  source: hgnc_alias_symbol
  hgnc_symbol: TNF
  entrez: '7124'
- word: AP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOSL2
  entrez: '2355'
- word: AP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: JUN
  entrez: '3725'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT1
  entrez: '6772'
- word: IRF3
  symbol: IRF3
  source: hgnc_symbol
  hgnc_symbol: IRF3
  entrez: '3661'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT2
  entrez: '6773'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT3
  entrez: '6774'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: TLR4
  symbol: TLR4
  source: hgnc_symbol
  hgnc_symbol: TLR4
  entrez: '7099'
- word: AP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOS
  entrez: '2353'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT5B
  entrez: '6777'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT6
  entrez: '6778'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK2
  entrez: '3717'
- word: AP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOSB
  entrez: '2354'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT5A
  entrez: '6776'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK1
  entrez: '3716'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT4
  entrez: '6775'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: TYK2
  entrez: '7297'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK3
  entrez: '3718'
chemicals:
- word: (+)-Naloxone
  source: MESH
  identifier: D009270
- word: (+)-Naltrexone
  source: MESH
  identifier: D009271
diseases: []
figid_alias: PMC4761092__F10
redirect_from: /figures/PMC4761092__F10
figtype: Figure
---
